Tobias Bald (@doc_bald) 's Twitter Profile
Tobias Bald

@doc_bald

I am a tumor biologist and immunologist studying the phenotypic plasticity of cells in the tumor microenvironment.

ID: 986463729893044224

linkhttp://www.baldlab.com calendar_today18-04-2018 04:37:35

109 Tweet

456 Followers

572 Following

QIMR Berghofer (@qimrb_institute) 's Twitter Profile Photo

Check out new GRAS Lab study on SARS-CoV-2 CD8+ T cell response. Well done to co-first authors Emma Grant and Dimitra from GRAS Lab and Katie Lineburg & Srividhya Swaminathan from @QIMRBerghofer

Anna Aschenbrenner (@aschenbrennerac) 's Twitter Profile Photo

🚹 JOB ALERTS 🚹 We are hiring! Fully funded PhD and Postdoc positions available! Come work with us! Schultze Lab Great team, infrastructure and scientific environment! đŸ—“ïž Apply until April 30!

Kerstin Ludwig (@k_u_ludwig) 's Twitter Profile Photo

Absolutely thrilled to see this work finally published! About 15 months ago I started on a journey which I could not have imagined before
 Interested in the story behind the scenes? My first-ever thread. 1/n

isb_bonn (@isbbonn) 's Twitter Profile Photo

We are happy to share the most recent publication from our Institute by PhD student @InesKalt describing Hip Kinases as a target of the FDA approved cancer drug Abemaciclib. Read the full article in Nature Communications here: nature.com/articles/s4146


Prof. Karl Lauterbach (@karl_lauterbach) 's Twitter Profile Photo

Dieser Text von Paul Offit, dem fĂŒhrenden Kinder Impfspezialisten in den USA, erklĂ€rt ĂŒberzeugend, weshalb auch Kinder im Alter 5-12 J geimpft werden sollten. Sehr lesenswert. Den Impfstoff werden wir bald auch in Deutschland haben, ich schĂ€tze vor Weihnachten

IEO_Bonn (@ieo_bonn) 's Twitter Profile Photo

đŸ„łAttention science enthusiastsđŸ„łWe are excited to announce the launch of our new IEO website. Check it out to find out more about our research and spread the word 🎉ieo.uni-bonn.de ImmunoSensation @HCM_Bonn Uniklinik Bonn Rheinische Friedrich-Wilhelms-UniversitĂ€t Bonn

IEO_HölzelLab (@ieo_holzellab) 's Twitter Profile Photo

CRP as biomarker to predict responses to immune checkpoint inhibitors in patients with metastatic renal cancer. Great potential for the clinic as simple and cost-effective. Congrats to Niklas KlĂŒmper Uniklinik Bonn and collaborators. onlinelibrary.wiley.com/doi/full/10.10


IEO_Bonn (@ieo_bonn) 's Twitter Profile Photo

New paper published by KlĂŒmper et al. about CRP as a biomarker in metastatic renal cancer. Congratulations to all collaborators🎉Niklas KlĂŒmper

IEO_Bonn (@ieo_bonn) 's Twitter Profile Photo

Longitudinal CRP kinetics (CRP Flare đŸ”„) predicts immunotherapy response within the first month in NSCLC! Great tool for therapy monitoring and as an integral biomarker for biomarker-directed study design Niklas KlĂŒmper Tobias Bald @IEO_BaldLab IEO_Bonn ImmunoSensation Rheinische Friedrich-Wilhelms-UniversitĂ€t Bonn

Tobias Bald (@doc_bald) 's Twitter Profile Photo

Longitudinal CRP kinetics (CRP Flare :fire:) predicts immunotherapy response within the first month in NSCLC! Great tool for therapy monitoring and as an integral biomarker for biomarker-directed study design Niklas KlĂŒmper Tobias Bald @IEO_BaldLab IEO_Bonn ImmunoSensation Rheinische Friedrich-Wilhelms-UniversitĂ€t Bonn

ImmunoSensation (@immunosens) 's Twitter Profile Photo

After 5 days of #science and networking, the ImmunoSensation2 SummerSchool "#Immunology at scales" comes to an end. We hope everyone had a great time at Schwanenwerda #Abendsonne 😉 Also want to be a #PhD #Student ImmunoSensation? 👉immunosensation.de/opportunities/


After 5 days of #science and networking, the ImmunoSensation2 SummerSchool "#Immunology at scales" comes to an end. We hope everyone had a great time at Schwanenwerda #Abendsonne 😉

Also want to be a #PhD #Student <a href="/ImmunoSens/">ImmunoSensation</a>? 👉immunosensation.de/opportunities/

Niklas KlĂŒmper (@niklas_kluemper) 's Twitter Profile Photo

Happy to share our work: Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma JAMA Oncology. See our tweetorial and the terrific editorial by Georges Gebrael Gliceida Galarza, MD Neeraj Agarwal, MD, FASCO UroToday.com 1/7

Michael Hölzel (@holzelmichael) 's Twitter Profile Photo

Excellent presentation by Gonzalo at the Single Domain Antibodies Meeting 2023 in Paris on his generic #CRISPR #CAR T cell platform! Important tool to improve #cellular #cancer #immunotherapies Rheinische Friedrich-Wilhelms-UniversitÀt Bonn⁩ ⁊ImmunoSensation⁩ ⁊@MSSOabcd⁩ ⁊IEO_GloddeLab⁩

Excellent presentation by Gonzalo at the Single Domain Antibodies Meeting 2023 in Paris on his generic #CRISPR #CAR T cell platform! Important tool to improve #cellular #cancer #immunotherapies <a href="/UniBonn/">Rheinische Friedrich-Wilhelms-UniversitÀt Bonn</a>⁩ ⁊<a href="/ImmunoSens/">ImmunoSensation</a>⁩ ⁊@MSSOabcd⁩ ⁊<a href="/IEO_GloddeLab/">IEO_GloddeLab</a>⁩
Niklas KlĂŒmper (@niklas_kluemper) 's Twitter Profile Photo

In three Phase III trials (mUC: IMvigor211, mRCC: IMmotion151, NSCLC: OAK) immunotherapy prolonged OS when baseline serum albumin was >35g/L -> Prediction of less immune fitness via simple albumin measurement?onlinelibrary.wiley.com/doi/10.1002/ct
 OncoAlert Clinical & Translational Immunology Tobias Bald IEO_Bonn